全文获取类型
收费全文 | 1780篇 |
免费 | 128篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 214篇 |
妇产科学 | 28篇 |
基础医学 | 208篇 |
口腔科学 | 39篇 |
临床医学 | 216篇 |
内科学 | 484篇 |
皮肤病学 | 28篇 |
神经病学 | 39篇 |
特种医学 | 236篇 |
外科学 | 163篇 |
综合类 | 52篇 |
预防医学 | 86篇 |
眼科学 | 16篇 |
药学 | 51篇 |
1篇 | |
肿瘤学 | 55篇 |
出版年
2023年 | 6篇 |
2021年 | 18篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 29篇 |
2017年 | 22篇 |
2016年 | 20篇 |
2015年 | 34篇 |
2014年 | 32篇 |
2013年 | 44篇 |
2012年 | 51篇 |
2011年 | 71篇 |
2010年 | 56篇 |
2009年 | 65篇 |
2008年 | 50篇 |
2007年 | 40篇 |
2006年 | 52篇 |
2005年 | 58篇 |
2004年 | 60篇 |
2003年 | 52篇 |
2002年 | 61篇 |
2001年 | 39篇 |
2000年 | 37篇 |
1999年 | 38篇 |
1998年 | 100篇 |
1997年 | 102篇 |
1996年 | 104篇 |
1995年 | 64篇 |
1994年 | 55篇 |
1993年 | 53篇 |
1992年 | 30篇 |
1991年 | 35篇 |
1990年 | 28篇 |
1989年 | 53篇 |
1988年 | 33篇 |
1987年 | 41篇 |
1986年 | 26篇 |
1985年 | 34篇 |
1984年 | 24篇 |
1983年 | 21篇 |
1982年 | 18篇 |
1981年 | 19篇 |
1980年 | 12篇 |
1978年 | 8篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 11篇 |
1971年 | 5篇 |
1969年 | 5篇 |
1966年 | 6篇 |
排序方式: 共有1920条查询结果,搜索用时 15 毫秒
1.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
2.
Treatment of dyskeratosis congenita with Granulocyte Colony-Stimulating Factor and Erythropoietin 总被引:1,自引:0,他引:1
Blanche P. Alter Frank H. Gardner & Robert E. Hall 《British journal of haematology》1997,97(2):309-311
Aplastic anaemia is both frequent and difficult to manage in patients with dyskeratosis congenita (DC). We recently treated a 23-year-old male for a year with granulocyte colony-stimulating factor (G-CSF) and erythropoietin (Ep), with an excellent neutrophil response, and a transient effect on haemoglobin levels. G-CSF alone or combined with other cytokines may provide at least a partial effect in pancytopenic patients with DC. 相似文献
3.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献4.
5.
6.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
7.
8.
Abhay Vats Kristen Gillingham Arthur Matas Blanche Chavers 《American journal of transplantation》2002,2(10):939-945
We evaluated variables associated with improved late graft survival in 290 children transplanted between 11/1/1984 and 12/31/1997, and who had > 1 year graft survival. We studied the following variables: age, gender, race, primary disease (diseases prone to recurrence, i.e. hemolytic uremic syndrome, focal segmental glomerulosclerosis or oxalosis vs. others), primary vs. retransplant; donor source, acute tubular necrosis, acute rejection episodes in the first year, transplant era and discharge serum creatinine. Graft half-life was defined as the time taken for 1/2 of the grafts functioning at 1 year to fail. There were 205 living donor and 85 cadaveric transplant. The cumulative graft survival at 5 and 10 years was 88% and 75% for living donor, and 72% and 46% for cadaveric, respectively. Multivariate analyses showed a higher late graft survival to be associated with: no acute rejection episodes (risk ratio 0.16, p = 0.0001), age 2-5 years (risk ratio 0.24, p = 0.0007), living donor (risk ratio 0.46, p = 0.017), primary nonrecurrent disease (risk ratio 0.29, p = 0.001), Caucasian race (risk ratio 0.40, p = 0.006). A high half-life was seen with living donor transplant (21.3 years) and the age group 2-5 years (27.5 years). Further, living donor patients with no acute rejection episodes had the best half-life of 37.6 years, while children with hemolytic uremic syndrome, focal segmental glomerulosclerosis or oxalosis had the lowest overall half-life of 5.6 years. This study finds that living donor, no acute rejection episodes, age 2-5 years, Caucasian race and having a disease not prone to recurrence are strong predictors of late graft survival. Hence, preferential use of living donor and prevention of acute rejection episodes in the first year are key variables that can improve long-term renal graft survival in children. 相似文献
9.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献
10.